VL6-15431-97661 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-31
Dose 1 — Pfizer-BioNTech
2021-04-01
Registered in v-safe
2021-04-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-03
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-14
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-21
Dose 2 — Pfizer-BioNTech
2021-04-21
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-05
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-12
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-21
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-07-21
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-20
Survey response — 6 months, dose 2
MedDRA: Nasopharyngitis — Feeling: Good

Free text: Cold

MedDRA releases: 2024-11 · check-in free text available
2021-10-26
Dose 3 — Pfizer-BioNTech
2022-01-25
Survey response — 3 months, dose 3
MedDRA: Pregnancy, Prenatal care — Feeling: Good · Get care from a doctor or other healthcare professional

Free text: Symptoms: Pregnancy · Healthcare visit (other): Routine prenatal care

MedDRA releases: 2024-11 · check-in free text available
2022-01-25
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

1 call case(s)
2022-02-02
Call 1 — Could Not Reach Participant
2022-02-07
Call 2 — Could Not Reach Participant
2022-04-26
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-06-21
Dose 4 — Moderna
2022-06-21
Health check-in — day 0, dose 4
Feeling: Good · Fever · None

Adult check-in
2022-06-22
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · None

Adult check-in
2022-06-23
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-07-28
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-08-02
Survey response — day 42, dose 4
MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school

Free text: Tested positive for COVID

MedDRA releases: 2024-11 · check-in free text available
2022-09-20
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-31	Pfizer-BioNTech
2	2021-04-21	Pfizer-BioNTech
3	2021-10-26	Pfizer-BioNTech	No
4	2022-06-21	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-01-25	Unsuccessful

Free text

Release 10 — 6 months, dose 2

2021-10-20

Symptoms: Cold

Release 11 — 3 months, dose 3

2022-01-25

Symptoms: Pregnancy

Healthcare visit (other): Routine prenatal care

Release 12 — day 42, dose 4

2022-08-02

Symptoms: Tested positive for COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Prenatal care	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pregnancy	·	·	✓
SD	SARS-CoV-2 test positive	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release